XHR enters the week with a notable disconnect: analyst targets are climbing while the stock is falling.
Wells Fargo raised its price target on XHR to $22 on July 23, the most bullish call on the name in years. That move follows a pattern of steady upgrades across the coverage universe — Wells Fargo has lifted its target four times since mid-2025, and Keybanc added its own raise in June, taking its target to $21. The Street consensus now sits at $21.20, implying around 4% upside from the current $20.44 close. Yet the stock has fallen 6.3% this week alone, leaving it trading at a discount to where most bulls expected it to be.
The borrow market tells a story of minimal conviction either way. Short interest is running at 4% of the free float — modest, and falling, down roughly 5% in the most recent session and nearly 17% from late June levels. Borrow is freely available, with availability running above 2,000% — meaning there are more than twenty shares available to lend for every one already borrowed. Cost to borrow is a negligible 0.43%, near a one-month low. Shorts are not pressing a thesis here. Options tell a slightly different story: the put/call ratio has edged up to 0.116, about 1.7 standard deviations above its 20-day average of 0.087. That's not extreme, but it is a shift — call-heavy positioning has been the norm all month, and the week's move into puts is worth noting.
The Street's bullish lean rests on earnings momentum that has been running exceptionally hot. EPS momentum ranks in the 97th–98th percentile over both 30-day and 90-day windows, and the 12-month forward EPS trajectory ranks in the 95th percentile — the forward estimates are moving sharply higher. The most recent earnings print, reported on July 30, saw the stock drop 5.7% in a single session, which may explain some of the current week's pressure. Against that backdrop, the EV/EBITDA multiple of 11.9x has edged lower over the past month, and the P/E at 35.6x has compressed by roughly 5 turns in 30 days — a re-rating that reflects the post-earnings reset rather than any deterioration in the underlying forecast.
The one friction point in an otherwise supportive institutional picture is the insider activity from earlier in the year. The CFO sold 120,000 shares at $17 in early May — a $2 million transaction — and the President/COO sold roughly 200,000 shares across two sessions in late February. Net insider activity over the 90 days through early May amounted to sales of over $5.6 million. Those sales occurred well below current levels, so they represent locked-in gains rather than a bearish read on the current price. Still, the absence of any purchase activity on record is a contrast to the analyst optimism.
The hotel REIT peer group has also been under pressure this week. RHP fell 5.7% on the week — almost mirroring XHR's decline — while APLE, SHO, and HST all gave back between 1.4% and 1.9%. DRH and RLJ held better, with DRH even posting a modest gain. The broad-based sector weakness suggests macro forces — softening travel demand, rate sensitivity — are driving more of XHR's price action than any company-specific factor. With no next earnings date yet flagged, the stock's near-term narrative will likely be shaped by any macro data or sector commentary that moves the lodging REIT complex as a whole.
See the live data behind this article on ORTEX.
Open XHR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
